Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the continued effects of Androxal on morning testosterone and reproductive status in men with secondary hypogonadism who have completed protocol ZA-203. Men w...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Repros Therapeutics Inc.
NCT07546435 · Psychological Experience in Fertility Treatment, Hypogonadism, and more
NCT06019182 · Intellectual Disability, Epilepsy, and more
NCT06689085 · Hypogonadism, Male
NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more
NCT06583408 · Hypothalamic Amenorrhea, Functional, Hypothalamic Amenorrhea, and more
Garden Grove, California
Sacramento, California
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions